ACM
SLDB icon

ADAR1 Capital Management’s Solid Biosciences SLDB Stock Holding History

ADAR1 Capital Management’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-34,479
Closed -$128K – 233
2025
Q1 		$128K Sell
34,479
-114,424
-77% -$490K 0.02% 158
2024
Q4 		$596K Sell
148,903
-996,689
-87% -$5.47M 0.12% 107
2024
Q3 		$7.98M Sell
1,145,592
-274,830
-19% -$2.23M 1.3% 16
2024
Q2 		$8.05M Buy
1,420,422
+1,217,218
+599% +$10.9M 1.52% 14
2024
Q1 		$2.71M Buy
203,204
+202,204
+20,220% +$1.89M 0.61% 33
2023
Q4 		$6.14K Buy
+1,000
New +$3.2K ﹤0.01% 142

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

ADAR1 Capital Management's SLDB Position: Q2 2025 in Review

ADAR1 Capital Management sold out of Solid Biosciences (SLDB) in Q2 2025, closing a stake of 34,479 shares — an estimated $128K sold.

ADAR1 Capital Management first reported a position in SLDB in Q4 2023 and held it in 6 quarters. The position peaked at $8.05M in Q2 2024. 114 funds tracked by Wall St. Rank hold SLDB as of Q2 2025.

  • ADAR1 Capital Management reported no remaining Solid Biosciences position as of Q2 2025 after selling out during the quarter.
  • ADAR1 Capital Management sold 34,479 Solid Biosciences shares in Q2 2025, an estimated $128K.
  • ADAR1 Capital Management first reported a position in Solid Biosciences in Q4 2023 and held it in 6 quarters.
  • ADAR1 Capital Management's Solid Biosciences position peaked at $8.05M in Q2 2024.
  • 114 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2025.

Based on ADAR1 Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.